Compare IMNM & HOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMNM | HOG |
|---|---|---|
| Founded | 2006 | 1903 |
| Country | United States | United States |
| Employees | N/A | 6400 |
| Industry | Medicinal Chemicals and Botanical Products | Motor Vehicles |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.9B |
| IPO Year | 2020 | 1994 |
| Metric | IMNM | HOG |
|---|---|---|
| Price | $19.53 | $26.89 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 15 |
| Target Price | ★ $35.20 | $27.90 |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 2.80% |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ 0.97 |
| Revenue | $6,941,000.00 | ★ $4,473,175,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18,747.97 | $3.81 |
| P/E Ratio | ★ N/A | $27.58 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.53 | $17.09 |
| 52 Week High | $30.06 | $28.86 |
| Indicator | IMNM | HOG |
|---|---|---|
| Relative Strength Index (RSI) | 30.12 | 54.99 |
| Support Level | $19.39 | $26.22 |
| Resistance Level | $23.48 | $28.76 |
| Average True Range (ATR) | 1.12 | 0.85 |
| MACD | -0.27 | 0.21 |
| Stochastic Oscillator | 13.81 | 78.88 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Harley-Davidson is a leading global manufacturer of heavyweight motorcycles across the custom, cruising, and touring categories, as well as related merchandise, parts, and accessories. In recent years, the firm has expanded into the adventure touring market with its Pan America model, into electric with the LiveWire brand, and is returning to smaller-displacement bikes with the Sprint. Its captive finance arm, Harley-Davidson Financial Services, provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley captured around 34% of the heavyweight domestic market in 2025.